• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期和晚期喉鳞状细胞癌的分子分化:一项探索性分析。

Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis.

作者信息

Saglam Ozlen, Shah Veena, Worsham Maria J

机构信息

Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.

出版信息

Diagn Mol Pathol. 2007 Dec;16(4):218-21. doi: 10.1097/PDM.0b013e3180d0aab5.

DOI:10.1097/PDM.0b013e3180d0aab5
PMID:18043285
Abstract

BACKGROUND

A current shortcoming in cancer prognostication and treatment is a lack of methods that adequately address the complexity and diversity of the disease. Prognostic marker systems based on single parameters have generally proven inadequate. Thus, multiparametric methods, which rely on many pieces of information, are ideally suited to the grouping of tumor subtypes and the identification of specific patterns of disease progression.

DESIGN

This study investigated, on an exploratory basis, whether genome wide alterations of loss and gain, using a panel of 122 gene probes (112 unique genes), discriminated between early stage (stage 1 and 2) and late stage (stage 3 and 4) laryngeal squamous cell carcinomas (LSCC). The LSCC cohort comprised 29 patients, 12 early and 17 late staged. Formalin-fixed LSCC DNA was interrogated by a genome wide candidate gene panel (122 genes) using the multiplex ligation-dependent probe amplification assay.

RESULTS

Statistical analysis employed the nonparametric Wilcoxon 2-sample test. Significant differences between tumor stages of early versus late were seen for the following genes: ERBB4, CASP2, RECQL4, and BCL7A. Loss of ERBB4 (P=0.045) and BCL7A (P=0.019) significantly discriminated between early and late stage LSCC. Gain of RECQL4 copy number (P=0.043) was associated with late LSCC. Gain of CASP2 (P=0.043) marked early LSCC, whereas loss was associated with late LSCC.

CONCLUSIONS

High-throughput genome wide approaches have the potential to yield discrete gene repertoires of early and late stage LSCC differentiation.

摘要

背景

癌症预后和治疗目前的一个不足之处在于缺乏能够充分应对该疾病复杂性和多样性的方法。基于单一参数的预后标志物系统通常已被证明是不够的。因此,依赖多条信息的多参数方法非常适合肿瘤亚型的分组以及疾病进展特定模式的识别。

设计

本研究基于探索性目的,调查使用一组122个基因探针(112个独特基因)进行全基因组缺失和增益改变是否能区分早期(1期和2期)和晚期(3期和4期)喉鳞状细胞癌(LSCC)。LSCC队列包括29例患者,其中12例为早期,17例为晚期。使用多重连接依赖探针扩增分析法,通过全基因组候选基因面板(122个基因)对福尔马林固定的LSCC DNA进行检测。

结果

统计分析采用非参数Wilcoxon双样本检验。在以下基因中观察到早期与晚期肿瘤阶段之间存在显著差异:ERBB4、CASP2、RECQL4和BCL7A。ERBB4(P = 0.045)和BCL7A(P = 0.019)的缺失显著区分了早期和晚期LSCC。RECQL4拷贝数的增加(P = 0.043)与晚期LSCC相关。CASP2的增加(P = 0.043)标志着早期LSCC,而其缺失与晚期LSCC相关。

结论

高通量全基因组方法有潜力产生早期和晚期LSCC分化的离散基因谱。

相似文献

1
Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis.早期和晚期喉鳞状细胞癌的分子分化:一项探索性分析。
Diagn Mol Pathol. 2007 Dec;16(4):218-21. doi: 10.1097/PDM.0b013e3180d0aab5.
2
Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays.利用激光捕获显微切割技术和互补DNA微阵列对喉鳞状细胞癌进行差异基因表达谱分析。
Arch Med Res. 2009 Feb;40(2):114-23. doi: 10.1016/j.arcmed.2008.12.005.
3
Clinicopathologic significance and prognostic role of cyclin E and cyclin A expression in laryngeal epithelial lesions.
Acta Otolaryngol. 2008 Mar;128(3):329-34. doi: 10.1080/00016480701487742.
4
[Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].[表面增强激光解吸/电离飞行时间质谱分析血清用于检测喉鳞状细胞癌及淋巴结转移进展]
Zhonghua Yi Xue Za Zhi. 2007 Sep 25;87(36):2526-30.
5
Expression of mucin gene products in laryngeal squamous cancer.
Otolaryngol Head Neck Surg. 2004 Jul;131(1):84-8. doi: 10.1016/j.otohns.2003.04.001.
6
[Laryngeal cancer and angiogenesis].[喉癌与血管生成]
Acta Otorhinolaryngol Ital. 1996 Aug;16(4):355-62.
7
[Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].[脆性组氨酸三联体基因(FHIT)表达与喉鳞状细胞癌细胞增殖及转移的相关性]
Ai Zheng. 2004 Nov;23(11):1338-41.
8
CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.CD24:喉鳞状细胞癌中的一种新型癌症生物标志物。
ORL J Otorhinolaryngol Relat Spec. 2012;74(2):78-85. doi: 10.1159/000335584. Epub 2012 Feb 21.
9
Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.基质金属蛋白酶-2在喉鳞状细胞癌中的过表达:预后不良的潜在指标。
Otolaryngol Head Neck Surg. 2005 Mar;132(3):395-400. doi: 10.1016/j.otohns.2004.09.050.
10
Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma.基因表达谱分析揭示了喉鳞状细胞癌的分子标志物候选物。
Oncol Rep. 2009 Mar;21(3):649-63.

引用本文的文献

1
Distinct prognosis of mRNA expression of the five RecQ DNA-helicase family members - , , , , and - in patients with breast cancer.乳腺癌患者中五种RecQ DNA解旋酶家族成员(、、、和)的mRNA表达具有不同的预后。
Cancer Manag Res. 2018 Dec 5;10:6649-6668. doi: 10.2147/CMAR.S185769. eCollection 2018.
2
Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma Using Proteomic and Transcriptomic Data.利用蛋白质组学和转录组学数据预测头颈部鳞状细胞癌分期的模型
IEEE J Biomed Health Inform. 2017 Jan;21(1):246-253. doi: 10.1109/JBHI.2015.2489158. Epub 2015 Oct 8.
3
Targeting HER (ERBB) signaling in head and neck cancer: An essential update.
靶向头颈部癌中的HER(ERBB)信号传导:重要更新
Mol Aspects Med. 2015 Nov;45:74-86. doi: 10.1016/j.mam.2015.07.001. Epub 2015 Jul 7.
4
Genetic alterations of chromosome 8 genes in oral cancer.口腔癌中8号染色体基因的遗传改变。
Sci Rep. 2014 Aug 15;4:6073. doi: 10.1038/srep06073.
5
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.乳腺癌中表皮生长因子受体/磷脂酰肌醇-3激酶/磷酸酶和张力蛋白同源物/蛋白激酶B/哺乳动物雷帕霉素靶蛋白复合物1信号通路的失调:治疗干预的可能性
Oncotarget. 2014 Jul 15;5(13):4603-50. doi: 10.18632/oncotarget.2209.
6
Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.表皮生长因子(EGF)家族在胃癌中的表达:HER4及其激活配体NRG4的下调
PLoS One. 2014 Apr 11;9(4):e94606. doi: 10.1371/journal.pone.0094606. eCollection 2014.
7
Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.通过反义寡核苷酸将 HER4 mRNA 表达导向 CYT2 同工型可降低乳腺癌细胞在体外和体内的生长。
Br J Cancer. 2013 Jun 11;108(11):2291-8. doi: 10.1038/bjc.2013.247. Epub 2013 May 21.
8
RECQL4 in genomic instability and aging.RECQL4 在基因组不稳定性和衰老中的作用。
Trends Genet. 2012 Dec;28(12):624-31. doi: 10.1016/j.tig.2012.08.003. Epub 2012 Aug 30.
9
Molecular characterization of head and neck cancer: how close to personalized targeted therapy?头颈部癌症的分子特征:离个体化靶向治疗还有多远?
Mol Diagn Ther. 2012 Aug 1;16(4):209-22. doi: 10.2165/11635330-000000000-00000.
10
Malignant and nonmalignant gene signatures in squamous head and neck cancer.头颈部鳞状细胞癌中的恶性和非恶性基因特征。
J Oncol. 2012;2012:752860. doi: 10.1155/2012/752860. Epub 2012 Apr 12.